FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 328:356-357 February 4, 1993 Number 5 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Single lesions that are enhanced during computed tomography (CT) with a contrast agent are frequently found in patients with partial seizures. Reports from the Indian subcontinent suggested that these lesions were tuberculomas¹; however, recent studies have shown that cysticercosis is the most common cause of such lesions². On the basis of these results, patients with partial seizures and single lesions enhanced on contrast CT usually receive symptomatic treatment and are reevaluated with CT after 8 to 12 weeks³. Further investigation is indicated only if the lesion has not disappeared by that time. Nevertheless, since . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Thussu, A, Chattopadhyay, A, Sawhney, I M S, Khandelwal, N (2008). Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy. J. Neurol. Neurosurg. Psychiatry 79: 272-275 [Abstract] [Full Text]  
• Singhi, P., Singhi, S. (2004). Topical Review: Neurocysticercosis in Children. J Child Neurol 19: 482-492 [Abstract]  
• Rajshekhar, V., Jeyaseelan, L. (2004). Seizure outcome in patients with a solitary cerebral cysticercus granuloma. Neurology 62: 2236-2240 [Abstract] [Full Text]  
• Garcia, H. H., Evans, C. A. W., Nash, T. E., Takayanagui, O. M., White, A. C. Jr., Botero, D., Rajshekhar, V., Tsang, V. C. W., Schantz, P. M., Allan, J. C., Flisser, A., Correa, D., Sarti, E., Friedland, J. S., Martinez, S. M., Gonzalez, A. E., Gilman, R. H., Del Brutto, O. H. (2002). Current Consensus Guidelines for Treatment of Neurocysticercosis. Clin. Microbiol. Rev. 15: 747-756 [Abstract] [Full Text]  
• Garg, R. K., Katti, M. K., Del Brutto, O. H. (2002). Proposed diagnostic criteria for neurocysticercosis. Neurology 58: 1315-1316 [Full Text]  
• Del Brutto, O. H., Rajshekhar, V., White, A. C. Jr., W. Tsang, V. C., Nash, T. E., Takayanagui, O. M., Schantz, P. M., Evans, C. A. W., Flisser, A., Correa, D., Botero, D., Allan, J. C., Sarti, E., Gonzalez, A. E., Gilman, R. H., Garcia, H.H. (2001). Proposed diagnostic criteria for neurocysticercosis. Neurology 57: 177-183 [Abstract] [Full Text]  
• Arun Kumar Baranwal, , Singhi, P. D., Singhi, S. C., Khandelwal, N. (2001). Seizure Recurrence in Children With Focal Seizures and Single Small Enhancing Computed Tomographic Lesions: Prognostic Factors on Long-Term Follow-up. J Child Neurol 16: 443-445 [Abstract]  
• Del Brutto, O. H. (1996). Medical Treatment for Cysticercosis-Reply. Arch Neurol 53: 295-296 [Abstract]  
• Carpio, A., Santillan, F., Leon, P., Flores, C., Hauser, W. A. (1995). Is the Course of Neurocysticercosis Modified by Treatment With Antihelminthic Agents?. Arch Intern Med 155: 1982-1988 [Abstract]  
• Del Brutto, O. H. (1995). Medical Treatment of Cysticercosis--Effective. Arch Neurol 52: 102-104 [Abstract]